Gold rose to an eight-week high as the dollar weakened with traders awaiting results from key elections in Georgia and weighing surging coronavirus cases. Platinum and palladium surged.
Medical-device makers are charging into 2021 poised for a fresh blast of deal making with soaring share prices and piles of cash at the ready.
State Street’s SPDR S&P 500 ETF Trust (SPY) just added $9.8 billion in a single day, according to data compiled by Bloomberg.
As the brutal technology rout deepens, exchange-traded fund investors are placing bets on value.
Gold advanced to a fresh record beyond $2,000 an ounce as investors assessed increased geopolitical risks and the prospect for further stimulus to combat fallout from the coronavirus pandemic.
Vanguard Group’s U.S. exchange-traded funds attracted inflows of about $89 billion in the first half, surging ahead of industry leader BlackRock Inc. in a volatile period.
One of Wall Street’s hottest innovations is being hailed as the potential key to luring trillions of actively managed dollars to the booming market for exchange-traded funds. Yet two of the industry’s biggest players want no part of it for now.
Gold headed toward the highest since 2012, supported by concerns over a second wave of coronavirus infections and ongoing expectations of a flood of stimulus measures.
Investors should be prepared for the possibility that the economy and markets might recover quicker than is currently priced in, according to Credit Suisse Group AG.
The largest homebuilder ETF surged to pre-crisis levels on data showing a surprise increase in sales of new houses last month.
Yale University’s publicly disclosed U.S. stock portfolio surged in value last quarter as the endowment added exchange-traded funds and technology shares during the coronavirus-fueled market plunge.